Latest News
News
FDA effort focuses on approving more generic drugs
Changes to how REMS are written for generic drugs could bring more to market.
Conference Coverage
Chemo-free regimen appears viable in previously untreated FL
CHICAGO – Could lenalidomide plus rituximab be a first-line option?
Conference Coverage
Prodige 7: No survival benefit with HIPEC for advanced colorectal cancer
HIPEC after surgery for colorectal peritoneal carcinomatosis provides no survival benefit and may cause harm, according to Prodige 7 trial...
Feature
ASH urges lawmakers to keep opioids accessible
The new policy statement seeks to balance addiction risks with the unique needs of hematology patients.
Conference Coverage
Avelumab does not add punch to ALK inhibitors for ALK+/– NSCLC
A combination of lorlatinib and avelumab showed good activity and acceptable safety against ALK-positive lung cancer, but no better efficacy than...
Conference Coverage
H&N cancer may be undertreated in women
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
Conference Coverage
Novel antibody shifts ‘eat me/don’t eat me’ balance in refractory NHL
CHICAGO – Treatment with Hu5F9-G4 (5F9) produced “encouraging” antitumor activity in a phase 1b study of 22 patients.
From the Journals
Smoking tied to localized prostate cancer recurrence, metastasis, death
In the first systematic review and meta-analysis to look at the link between smoking and outcomes after localized prostate cancer primary therapy...
Conference Coverage
TAILORx marks major advance for precision medicine in breast cancer
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate...
News
Emicizumab gets priority review for hemophilia A without inhibitors
The Food and Drug Administration is expected to make an approval decision on emicizumab in October 2018.
Conference Coverage
Statin effect in prostate cancer may be caused by reduced inflammation
SAN FRANCISCO – Statin use is associated with lower lethality in prostate cancer. A new genetic analysis points to reduced inflammation in the...